Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

MLA

Karaca, Irmak, et al. “Intravenous Cyclophosphamide Therapy for Patients with Severe Ocular Inflammatory Diseases Who Failed Other Immunomodulatory Therapies.” Journal of Ophthalmic Inflammation & Infection, vol. 14, no. 1, Mar. 2024, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s12348-023-00372-z.

APA

Karaca, I., Tran, E. M., Park, S., Bromeo, A., Khojasteh, H., Tran, A. N. T., Yavari, N., Akhavanrezayat, A., Yasar, C., Uludag Kirimli, G., Than, N. T. T., Hassan, M., Or, C., Ghoraba, H., Do, D. V., & Nguyen, Q. D. (2024). Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. Journal of Ophthalmic Inflammation & Infection, 14(1), 1–6. https://doi.org/10.1186/s12348-023-00372-z

Chicago

Karaca, Irmak, Elaine M. Tran, SungWho Park, Albert Bromeo, Hassan Khojasteh, Anh Ngọc Tram Tran, Negin Yavari, et al. 2024. “Intravenous Cyclophosphamide Therapy for Patients with Severe Ocular Inflammatory Diseases Who Failed Other Immunomodulatory Therapies.” Journal of Ophthalmic Inflammation & Infection 14 (1): 1–6. doi:10.1186/s12348-023-00372-z.